Literature DB >> 6792034

Localization and quantitation of a low molecular weight proteinase inhibitor, antileukoprotease, in the human uterus.

B Casslén, M Rosengren, K Ohlsson.   

Abstract

Antileukoprotease was demonstrated in the cervical mucosa, but was absent in the endometrium. It was shown immunohistologically to predominate in the epithelial lining of the cervical crypts. High concentrations were found in the cervical mucus. Although antileukoprotease was not present in the endometrium, low concentrations were found in the uterine fluid, probably secondary to diffusion from the cervical mucus. The concentration of antileukoprotease in cervical mucus varied greatly during the menstrual cycle, but no midcycle minimum was found. Increased concentrations were found in samples obtained during the week preceding onset of the menstruation in most women. Antileukoprotease was present in uterine fluid from intra uterine device (IUD) non-users in its free form. In fluid from IUD users it was partly in its free form, and partly in a complexed form. The major part of the non-complexed portion was biologically active. The complex consisted, at least partly, of elastase bound to antileukoprotease. Antileukoprotease may thus contribute to the neutralization of granulocyte elastase in the uterine fluid of IUD users.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6792034     DOI: 10.1515/bchm2.1981.362.2.953

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  9 in total

1.  Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteases.

Authors:  G Stetler; M T Brewer; R C Thompson
Journal:  Nucleic Acids Res       Date:  1986-10-24       Impact factor: 16.971

2.  Conditionally reprogrammed macaque endocervical cells retain steroid receptor expression and produce mucus.

Authors:  Leo Han; Walker Andrews; Karsten Wong; Jeffrey T Jensen
Journal:  Biol Reprod       Date:  2020-05-26       Impact factor: 4.285

3.  Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers.

Authors:  H Hocini; P Becquart; H Bouhlal; H Adle-Biassette; M D Kazatchkine; L Bélec
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

Review 4.  Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections.

Authors:  Charles R Wira; Mickey V Patel; Mimi Ghosh; Lucy Mukura; John V Fahey
Journal:  Am J Reprod Immunol       Date:  2011-03       Impact factor: 3.886

5.  Localization of immunoreactive secretory leukocyte protease inhibitor (SLPI) in intestinal mucosa.

Authors:  M Bergenfeldt; M Nyström; M Bohe; C Lindström; A Polling; K Ohlsson
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

6.  Protease-antiprotease levels and whole-blood chemiluminescence in acute peritonitis.

Authors:  M Bergenfeldt; K Ohlsson
Journal:  Gastroenterol Jpn       Date:  1993-10

7.  Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.

Authors:  R Berling; A Borgström; K Ohlsson
Journal:  Int J Pancreatol       Date:  1998-08

8.  Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells.

Authors:  M Nyström; M Bergenfeldt; I Ljungcrantz; A Lindeheim; K Ohlsson
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

Review 9.  Innate immune defences in the human endometrium.

Authors:  Anne E King; Hilary O D Critchley; Rodney W Kelly
Journal:  Reprod Biol Endocrinol       Date:  2003-11-28       Impact factor: 5.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.